Publication:
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey.

dc.contributor.authorHoste, Levi
dc.contributor.authorSoriano-Arandes, Antoni
dc.contributor.authorBuddingh, Emilie Pauline
dc.contributor.authorWhittaker, Elizabeth
dc.contributor.authorBelot, Alexandre
dc.contributor.authorUlloa-Gutierrez, Rolando
dc.contributor.authorOlbrich, Peter
dc.contributor.authorHaerynck, Filomeen
dc.contributor.groupMIS-C researchers
dc.date.accessioned2023-05-03T15:05:47Z
dc.date.available2023-05-03T15:05:47Z
dc.date.issued2022-09
dc.description.abstractThe optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C.
dc.description.versionSi
dc.identifier.citationHoste L; MIS-C researchers; Soriano-Arandes A, Buddingh EP, Whittaker E, Belot A, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey. J Pediatr. 2022 Sep;248:114-118.
dc.identifier.doi10.1016/j.jpeds.2022.05.028
dc.identifier.essn1097-6833
dc.identifier.pmcPMC9119291
dc.identifier.pmid35598642
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119291/pdf
dc.identifier.unpaywallURLhttps://digital.csic.es/bitstream/10261/279790/1/Severe%20Acute%20Respiratory%20Syndrome%20Coronavirus%202%20Vaccination%20in%20Children.pdf
dc.identifier.urihttp://hdl.handle.net/10668/22331
dc.journal.titleThe Journal of pediatrics
dc.journal.titleabbreviationJ Pediatr
dc.language.isoen
dc.organizationHospital Universitario Virgen del Rocío
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.page.number114-118
dc.provenanceRealizada la curación de contenido 11/07/2025.
dc.publisherElsevier Inc.
dc.pubmedtypeCase Reports
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.relation.publisherversionhttps://linkinghub.elsevier.com/retrieve/pii/S0022-3476(22)00438-3
dc.rightsAtribución-NoComercial-SinDerivadas 4.0 Internacional
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectCOVID-19
dc.subjectMIS-C
dc.subjectSARS-CoV-2
dc.subjectadverse events
dc.subjectvaccination
dc.subject.decsSíndrome de respuesta inflamatoria sistémica
dc.subject.decsSARS-CoV-2
dc.subject.decsPandemias
dc.subject.decsSíndrome de Guillain-Barré
dc.subject.decsVacuna BNT162
dc.subject.decsInsuficiencia respiratoria
dc.subject.decsEnfermedad aguda
dc.subject.meshCOVID-19
dc.subject.meshChild
dc.subject.meshHumans
dc.subject.meshSARS-CoV-2
dc.subject.meshSurveys and Questionnaires
dc.subject.meshSystemic Inflammatory Response Syndrome
dc.subject.meshVaccination
dc.titleSevere Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey.
dc.typereport
dc.type.hasVersionVoR
dc.volume.number248
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC9119291.pdf
Size:
646.84 KB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Hoste_SevereAcute_MaterialSuplementario.zip
Size:
1.15 MB
Format: